CVR: 39022508
Secondary names: Løgstørvej 80 ApS
Previous names: S. Greenhouse ApS, Løgstørvej 80 ApS
DKK 223,313
Gross profit
Net result: DKK 136,379
A.T.L. Holding ApS
CVR · view ownership and management
Director role ended: Carsten Egebæk Kjeldsen
CVR · 18/11/2025
View the full event history
TCM Pharma ApS was a Danish company of the type Anpartsselskab based in Farsø, founded in 2017. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Løgstørvej 80 ApS and S. Greenhouse ApS. The company is owned by A.T.L. Holding ApS. In 2023, the company reported a gross profit of DKK 223,313 and a net result of DKK 136,379 compared with DKK -163,358 the year before. Equity in the 2023 report amounted to DKK 53,353.
Selskabets formål er at forestå farmaceutisk forarbejdning, herunder eje og udleje bygning og materiel til brug herfor.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/01/2023 – 31/12/2023 | 223 t. | 136 t. | 503 t. | 53 t. | 0 | |
| 202201/01/2022 – 31/12/2022 | 159 t. | -163 t. | 943 t. | -283 t. | 0 | |
| 202101/01/2021 – 31/12/2021 | 458 t. | 134 t. | 1.3 mio. | -214 t. | - | |
| 202001/01/2020 – 31/12/2020 | 67 t. | -276 t. | 1.1 mio. | -348 t. | 0 | |
| 201901/01/2019 – 31/12/2019 | -17 t. | -114 t. | 1.3 mio. | -72 t. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Regnskab og boafslutning i konkursboet TCM Pharma ApS, Retten i Aalborg, sagsnr. SKS 31-592/2025.
Source: Statstidende — updated daily
Screen owners and management against the Danish FSA's official PEP lists
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationTCM Pharma ApS is registered in the Danish CVR register with the status Under bankruptcy.
TCM Pharma ApS was founded on 18 October 2017.
TCM Pharma ApS was registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
TCM Pharma ApS is owned by A.T.L. Holding ApS.
In 2023, TCM Pharma ApS reported a gross profit of DKK 223,313.
TCM Pharma ApS was located at Hestbækvej 93, 9640 Farsø.
Contact info changed: new phone: 40411544 (July 18, 2026).
On July 18, 2026, TCM Pharma ApS was placed under bankruptcy proceedings.
On July 16, 2026, a notice regarding TCM Pharma ApS was published in Statstidende: Regnskab og boafslutning (S14072026-35).
As of November 18, 2025, Carsten Egebæk Kjeldsen has stepped down as liquidator of TCM Pharma ApS.
On November 18, 2025, TCM Pharma ApS exited liquidation.
As of November 4, 2025, Carsten Egebæk Kjeldsen is registered as liquidator of TCM Pharma ApS.
On November 4, 2025, TCM Pharma ApS entered liquidation.
As of August 12, 2025, Lars Goul Nielsen has stepped down as director of TCM Pharma ApS.
TCM Pharma ApS has published its annual report for 2023. Gross profit came to DKK 223,313, and the net result was DKK 136,379.
TCM Pharma ApS has published its annual report for 2022. Gross profit came to DKK 158,887, and the net result was DKK -163,358.
TCM Pharma ApS has published its annual report for 2021. Gross profit came to DKK 458,269, and the net result was DKK 133,616.
As of August 5, 2022, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of TCM Pharma ApS.
As of July 6, 2022, A.T.L. Holding ApS is registered as an owner of TCM Pharma ApS with an ownership share of 90%.
As of April 27, 2022, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of TCM Pharma ApS.
As of April 27, 2022, ANDERSEN REVISION STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of TCM Pharma ApS.
On January 21, 2022, the company changed its name from Løgstørvej 80 ApS to TCM Pharma ApS.
TCM Pharma ApS has published its annual report for 2020. Gross profit came to DKK 66,690, and the net result was DKK -275,872.
TCM Pharma ApS has published its annual report for 2019. Gross profit came to DKK -16,577, and the net result was DKK -113,842.
On October 7, 2019, the company changed its name from S. Greenhouse ApS to Løgstørvej 80 ApS.
TCM Pharma ApS has published its interim report for the period October 18, 2017 – December 31, 2018.
As of November 21, 2018, ANDERSEN REVISION STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of TCM Pharma ApS.
As of November 21, 2018, A/S PSE 17 NR. 1056 has stepped down as auditor of TCM Pharma ApS.
As of October 18, 2017, A/S PSE 17 NR. 1056 has been appointed auditor of TCM Pharma ApS.
As of October 18, 2017, Lars Goul Nielsen is registered as director of TCM Pharma ApS.
TCM Pharma ApS was founded on October 18, 2017.
